Abstract
The case of an infant born to a mother receiving continuous propranolol therapy throughout pregnancy isreported. Perinatal problems included: a small placenta, intrauterine growth retardation, fetal depression at birth, and postnatal hypoglycemia and bradycardia. These responses appeared to be the direct result of the maternal use of propranolol. Hence, infants born to mothers on continuous therapy with this agent should be considered at risk for developing these complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
